🇺🇸 FDA
Patent

US 7449570

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

granted A61KA61K31/506A61K31/7072

Quick answer

US patent 7449570 (Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases) held by PTC THERAPEUTICS, INC. expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/506, A61K31/7072, A61P, A61P25/00